Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

176
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on NOVARTIS AG
11/10 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
11/10 MOMENTA PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results
11/10 NOVARTIS : Canadian results from first global survey of neuroendocrine tumour (N..
11/10 JIANGSU HENGRUI MEDICINE : Sandoz Team Up in Selling Drugs
11/10 NOVARTIS : to reveal landmark Phase III data for AIN457 (secukinumab) in psoriat..
11/10 NOVARTIS : to reveal landmark Phase III data for AIN457 (secukinumab) in psoriat..
11/10 NOVARTIS : to reveal landmark Phase III data for AIN457 (secukinumab) in psoriat..
11/07 NOVARTIS : CCP opens 2nd phase review on Novartis pre-merger application
11/07 NOVARTIS : CCP opens second phase review of oncology products
11/07 NOVARTIS : Lt. Governor Guadagno Celebrates Grand Opening of Sandoz, Inc.'s New ..
11/07 NOVARTIS : Alcon Surgical Names HCB Health Agency of Record
11/06 NOVARTIS : announces outcome of FDA advisory committee meeting for multiple myel..
11/06 NOVARTIS : announces outcome of FDA advisory committee meeting for multiple myel..
11/06 NOVARTIS : announces outcome of FDA advisory committee meeting for multiple myel..
11/06DJBIOSIMILARS : The Good, the Bad and the Unknown -- Barron's
11/06 NOVARTIS : Sources Sought Notice - J-- Preventive maintenance services and repai..
11/06 NOVARTIS : Sources Sought - Preventive maintenance services and repair for Alcon..
11/06 CIPLA : Launches low-cost generic respiratory drug
11/05 Analysis - Drugmakers look to push the boundaries of old age
11/05 NOVARTIS : Patent Issued for Disintegrable Oral Films
11/05 CSL : to acquire Novartis' influenza vaccine business
11/05 INCYTE : Reports 2014 Third-Quarter Financial Results and Updates Shareholders o..
11/05DJBIOSIMILARS : The Good, the Bad and the Unknown -- Barron's
11/05 NOVARTIS : XBiotech Adds Daniel Vasella to its Board of Directors
11/05 CIPLA : Asks government to revoke novartis patent, launches drug
11/05 NOVARTIS : Pharmaceuticals Assigned Patent
11/05 Behind the deal
11/04 VECTURA : Gets Approval For AirFluSal Forspiro In Baltic States
11/04 CIPLA : Novartis patent row
11/04 INCYTE : Posts 2014 3Q Financial Results
11/03 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
11/03 NOVARTIS : Lays Off 75 Employees At Lincoln Plant
11/03 NOVARTIS : Oxford BioMedica Interim Management Statement
11/03 OXFORD BIOMEDICA : Says It Could Become Cash Positive On Novartis Deal
10/31 NOVARTIS : Cipla in patent fight (drug war)
10/30 Ranbaxy sees first profit in six qtrs on Diovan sales
10/30 RANBAXY TURNS AROUND, POSTS Rs478-CRORE PROFIT IN Q2
10/29 NOVARTIS : European shares rise
10/29 NOVARTIS : Psoriasis is so much more than a skin disease and has effects on peop..
10/29DJNorway's Oil Fund Posts Flat Returns in 3Q
10/29DJNorway's Oil Fund Posts Flat Returns in 3Q--Update
10/28 NOVARTIS : New Report Available: Cough, Cold and Allergy (Hay Fever) Remedies in..
10/28 Ranbaxy surges after profit, Sun Pharma also gains
10/28DJEuropean Stocks Rebound But Investors Remain Cautious -- 3rd Update
10/28DJEUROPE MARKETS : European Stocks Rebound; Stoxx 600 Up 1%
10/28DJEuropean Stocks Rise But Investors Remain Cautious --2nd Update
10/28 NOVARTIS : Eyecheck Systems, Alcon Research Assigned Patent
10/28DJEuropean Stocks Rise But Investors Remain Cautious --Update
10/28 NOVARTIS : Alcon Research Assigned Patent
10/28DJEUROPE MARKETS : European Stocks Rebound; Stoxx 600 Up 0.7%
10/28 Novartis results top forecasts as new products gain momentum
10/28 NOVARTIS : sees new heart failure drug as 'multi-blockbuster'
10/28 NOVARTIS : Swiss drug maker Novartis posts strong profit
10/28 NOVARTIS : delivered solid sales growth with strong margin expansion and major i..
10/28 NOVARTIS : FDA Advisory Committee Recommends Approval of AIN457 (secukinumab) fo..
10/27 CSL : Australian biotech CSL to acquire influenza vaccine business of Novartis f..
10/27 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
10/27 CSL : Novartis selling flu vaccine unit to CSL for $275M
10/27 CSL : Novartis agrees to sell its flu vaccine business to CSL of Australia for $..
10/27 CSL : to acquire Novartis' influenza vaccine business
10/26 NOVARTIS : To Divest Influenza Vaccines Business To CSL $275 Mln
10/26DJCSL to Buy Novartis Influenza-Vaccine Unit
10/26DJCSL to Buy Novartis Influenza-Vaccine Unit for $275 Million
10/26 NOVARTIS : announces divestiture of influenza vaccines business to CSL for USD 2..
10/26 NOVARTIS : announces divestiture of influenza vaccines business to CSL for USD 2..
10/23DJNovartis 3Q 2014 -- Forecast
10/23 NOVARTIS : Patent Issued for Devices and Methods for Holding an Intraocular Lens..
10/23 NOVARTIS : reports positive results in spinal inflammation condition
10/23 NOVARTIS : FDA Advisory Committee Recommends Approval of AIN457 (secukinumab) fo..
10/23 NOVARTIS : AIN457 (secukinumab) meets primary endpoint in two Phase III studies ..
10/23 NOVARTIS : AIN457 (secukinumab) meets primary endpoint in two Phase III studies ..
10/23 NOVARTIS : AIN457 (secukinumab) meets primary endpoint in two Phase III studies ..
10/22 NOVARTIS : Patent Application Titled "Automated Intraocular Lens Injector Device..
10/22 NOVARTIS : announces CTL019 data published in NEJM demonstrating efficacy in cer..
10/22 GSK eyes prime FTSE 100 slot for standalone HIV drugs business
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF